Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSevere diarrhoea on Mounjaro is reported by some people, particularly in the first few weeks of treatment or after a dose increase. For most, loose stools settle within days to a couple of weeks as the body adjusts. But sometimes diarrhoea is intense enough to raise a real question: is this a normal side effect, or a sign that something needs medical attention? That distinction is worth understanding before you dismiss it. Mounjaro (tirzepatide) is a prescription-only medicine, and a prescriber reviews your health picture before treatment begins — side-effect management is part of that ongoing clinical relationship, not an afterthought. The NHS medicines page for tirzepatide lists diarrhoea among the common side effects, but it also describes when GI symptoms cross into territory requiring care.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide slows the speed at which food leaves the stomach. That shift has benefits for appetite and blood-sugar control, but the gut takes time to adapt. The most common result is loose or frequent stools, particularly in the first month. For many people the experience is mild: an extra trip to the bathroom, some urgency, stools that are softer than usual. That is the gut adjusting, and it tends to pass.
Extreme diarrhoea is a different picture. If you are running to the toilet multiple times a day, stools are entirely watery, or the pattern continues beyond two weeks without any sign of easing, that goes beyond typical adjustment. The same applies if diarrhoea returns sharply after you had already settled at a particular dose, a pattern worth flagging to your prescriber rather than riding out alone.
There is nothing weak about finding GI side effects difficult. Our prescribers hear this regularly: people who coped well for two months and then had a rough week after stepping to a higher dose. The full side-effect profile for Mounjaro covers the broader range of what people experience, which puts diarrhoea in context alongside other GI effects, including how extreme nausea on Mounjaro can accompany or be confused with gut-related symptoms.
The most immediate risk from severe diarrhoea is dehydration. Tirzepatide can reduce thirst signals alongside appetite, which means some people do not realise how much fluid they have lost until they feel lightheaded, very fatigued, or notice their urine has darkened. Dehydration that is not corrected can affect kidney function, and that is a reason to seek help rather than push through.
Signs that mean you should contact a doctor or call 111 without delay include: diarrhoea that has lasted more than a few days and shows no improvement; signs of dehydration (dizziness, very dark urine, feeling faint); blood in your stool; or severe cramping that is getting worse rather than better.
Separately, pay attention to any abdominal pain that is severe and persistent, particularly if it radiates towards your back. The MHRA's January 2026 Drug Safety Update highlighted that acute pancreatitis (though infrequent) is a known serious side effect of GLP-1 medicines. Pancreatitis can present alongside or mimic GI symptoms. If you have intense, worsening stomach pain, do not wait to see if it settles. Get medical help the same day.
You can find further detail on symptoms to watch for in our guide to managing Mounjaro-related diarrhoea, which also covers practical day-to-day steps.
Several things are known to aggravate GI side effects on tirzepatide. High-fat meals, very large portions and alcohol all tend to intensify the effect. Eating slowly, keeping portions modest, and reducing fat content during the first weeks of each dose step can meaningfully reduce the frequency and severity of loose stools for many people.
Hydration matters more than usual. Sipping water steadily throughout the day replaces what the gut is losing, and oral rehydration solutions can help if diarrhoea has been frequent. Caffeine and fizzy drinks may worsen urgency for some people, so plain water or diluted squash is a better default.
Timing plays a role too. Some people find that injecting on a Friday or Saturday evening (rather than mid-week) means any rough first few days land over a weekend rather than a working Monday. If your schedule is less flexible around certain periods (the week before payday, a busy project, a holiday trip), it is worth building that into when you choose to step up a dose. That is a conversation worth having with your prescriber.
If diarrhoea is significantly affecting daily life, do not simply reduce fluid intake or skip doses without speaking to a clinician. A prescriber may suggest a slower titration pace, which is a legitimate and common approach. If fatigue is layering on top of your GI symptoms, our guide to extreme fatigue on Mounjaro covers how those two effects can compound each other, and our separate page on extreme tiredness on Mounjaro goes into further detail on why that particular symptom develops and what to do about it.
Every patient on a prescription medicine in the UK has the right to report side effects directly to the MHRA via the Yellow Card scheme. You do not need a GP or pharmacist to submit a report on your behalf. Reporting genuine side effects, including severe diarrhoea, helps regulators build a clearer picture of how medicines perform in real-world use, it is useful even if your side effect resolves without medical intervention.
Tirzepatide carries a Black Triangle (▼) designation, which means it is under additional monitoring. That makes Yellow Card reports from patients particularly valuable right now.
At the same time, reporting to the MHRA is separate from seeking care. If your symptoms are serious or worsening, contact your prescriber or 111 first. The Yellow Card report can follow once you have been assessed.
If you are considering Mounjaro and want to understand how side effects are discussed as part of the assessment, the prescribers at our clinical team cover suitability and side-effect risks in every consultation. You can also read a broader overview of what Mounjaro treatment involves on the Mounjaro information page. When you are ready to discuss your own situation, start your free consultation and a GPhC-registered prescriber will review it the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.